Pfizer (PFE) updates Durect (DRRX) on Remoxy, saying that it's "considering its options", and...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) updates Durect (DRRX) on Remoxy, saying that it's "considering its options", and that if it elects to continue development of Remoxy, "we would not expect to submit a response to the "complete response" letter before mid-2015." (PR) This is less positive than expected by SA author Jason Napodano; shares are -12.6% premarket.